Medicenna Therapeutics Current Cash

Medicenna Therapeutics (MDNAF) currently reports a current cash of $26M as of September 2023. That compares with $40M in the prior-year period — down 35.8% year over year. Use the charts on this page to explore Medicenna Therapeutics's current cash history and peer comparisons.

Medicenna Therapeutics's current cash decreased from $40M to $26M — a 35.8% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicenna Therapeutics reported $26M in current cash as of September 2023. That compares with $40M in the prior-year period — down 35.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicenna Therapeutics, and consider following MDNAF for alerts when major investors trade the stock.

Medicenna Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $26M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDNAF with unrelated industries.